Development of urea-bridged cyclic dominant negative pneumococcus competence-stimulating peptide analogs

Area of Science:

• Medicinal Chemistry
• Structural Biology
• Microbiology

Background:

• Peptide cyclization is crucial for conformational restraint in linear peptides.
• Urea bridge chemistry offers a novel method for side chain-to-side chain peptide cyclization.
• The Streptococcus pneumoniae CSP1-E1A peptide scaffold is a target for therapeutic development.

Purpose of the Study:

• To investigate the impact of ring size and bridge position on peptide conformation and biological activity.
• To identify optimal cyclization strategies for the CSP1-E1A peptide.
• To enhance understanding of peptide-receptor interactions.

Main Methods:

• Synthesis of cyclic peptide analogs using urea bridge chemistry.
• Biological evaluation of peptide-receptor binding affinity (CSP1-E1A and ComD).
• Secondary structure analysis using Circular Dichroism (CD) and Trapped Ion Mobility Spectrometry (TIMS).

Main Results:

• Minor modifications in cyclic analogs, particularly bridge position, significantly altered peptide-ComD receptor interactions.
• Structural analysis confirmed the importance of bridge position as a key modification parameter.
• Both ring size and bridge position influence peptide conformation and biological activity.

Conclusions:

• Comprehensive conformational screening, including bridge position, is essential for fine-tuning cyclic peptide analog secondary structures.
• This approach can optimize peptide:protein interactions for therapeutic applications.
• The study provides valuable insights for designing improved peptide-based therapeutics.